MedTrace Logo

Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

NCT04096794 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-04-21

No results posted yet for this study

Summary

The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.

Conditions

  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04096794 on ClinicalTrials.gov